MICRON TECHNOLOGY INC
MUNASDAQ$983.23▲ $54.43 (+5.86%)
🌙 After hours$958.88▼ 2.48%Regular close · extended-hours price shownTrack MU
Get earnings, price moves & breaking news on Telegram
24h▲ 5.9%
7d▲ 14.9%
14d▲ 5.6%
30d▼ 7.7%
ytd▲ 244.4%
1y▲ 334.0%
🏦Market Cap
$1.11T
Mega Cap
📈Revenue Growth (YoY)
256.3%
High Growth
📊Gross Margin
80.7%
High
💵FCF Margin
44.3%
Strong
⚖️P/S Ratio
8.4x
Elevated
Otter Score
72
Strong
MICRON TECHNOLOGY INC
MUAnalyst Ratings
Price
$983.23
Total
70
Raised
6
Lowered
9
Avg PT
$1588.85
H / L
$3000 / $1200
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Needham | Reiterated | Buy | 2026-10-22 | $1650.00 | +67.80% |
Rosenblatt | Reiterated | Buy | 2026-10-22 | — | — |
DA Davidson | Reiterated | Buy | 2026-10-07 | $3000.00 | +205.10% |
Morgan Stanley | Reiterated | Overweight | 2026-10-01 | $1200.00 | +22.00% |
Mizuho | Reiterated | Outperform | 2026-10-01 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2026-10-01 | $2000.00 | +103.40% |
RBC Capital | Reiterated | Outperform | 2026-10-01 | $1500.00 | +52.60% |
TD Cowen | Reiterated | Buy | 2026-10-01 | — | — |
Baird | Reiterated | Outperform | 2026-09-28 | — | — |
Wedbush | Reiterated | Outperform | 2026-09-28 | $1400.00 | +42.40% |
Wells Fargo | Reiterated | Overweight | 2026-09-23 | $1400.00 | +42.40% |
Citigroup | Reiterated | Buy | 2026-09-23 | — | — |
New Street Research | Upgraded | Neutral → Buy | 2026-08-14 | — | — |
Keybanc | Reiterated | Overweight | 2026-07-14 | $1750.00 | +78.00% |
B of A Securities | Reiterated | Buy | 2026-06-25 | — | — |
Susquehanna | Reiterated | Positive | 2026-06-25 | $2000.00 | +103.40% |
Deutsche Bank | Reiterated | Buy | 2026-06-25 | $1550.00 | +57.60% |
Raymond James | Reiterated | Outperform | 2026-06-25 | $1500.00 | +52.60% |
Barclays | Reiterated | Overweight | 2026-06-25 | $2000.00 | +103.40% |
Goldman Sachs | Reiterated | Neutral | 2026-06-25 | $1250.00 | +27.10% |
Stifel | Reiterated | Buy | 2026-06-18 | — | — |
Wolfe Research | Reiterated | Outperform | 2026-06-11 | $1300.00 | +32.20% |
UBS | Reiterated | Buy | 2026-05-26 | $1540.00 | +56.60% |
Melius Research | Reiterated | Buy | 2026-05-19 | $2200.00 | +123.80% |
JP Morgan | Reiterated | Overweight | 2026-03-19 | — | — |
Bernstein | Reiterated | Outperform | 2026-03-18 | $1300.00 | +32.20% |
Lynx Global | Reiterated | Buy | 2026-01-12 | — | — |
Piper Sandler | Reiterated | Overweight | 2026-01-07 | $400.00 | −59.30% |
China Renaissance | Downgraded | Buy → Hold | 2025-03-26 | — | — |
Exane BNP Paribas | Downgraded | Outperform → Underperform | 2024-09-12 | — | — |
Argus Research | Upgraded | Hold → Buy | 2024-03-21 | — | — |
Evercore ISI Group | Reiterated | Outperform | 2023-12-21 | — | — |
BMO Capital | Reiterated | Outperform | 2023-12-18 | $1300.00 | +32.20% |
Credit Suisse | Reiterated | Outperform | 2022-11-16 | — | — |
Loop Capital | Reiterated | Buy | 2022-10-14 | — | — |
Summit Insights Group | Upgraded | Hold → Buy | 2022-09-30 | — | — |
Fox Advisors | Downgraded | Overweight → Equal Weight | 2022-07-05 | — | — |
Cowen & Co. | Reiterated | Outperform | 2022-07-01 | — | — |
Cascend | Reiterated | Buy | 2021-03-15 | — | — |
KeyBanc | Reiterated | Overweight | 2021-03-04 | $1750.00 | +78.00% |
Cleveland Research | Upgraded | Neutral → Buy | 2020-09-23 | — | — |
Nomura | Reiterated | Neutral | 2020-06-30 | — | — |
Nomura Instinet | Reiterated | Neutral | 2020-06-30 | — | — |
Longbow Research | Reiterated | Buy | 2020-01-21 | — | — |
GF Securities | Reiterated | Accumulate → Buy | 2019-11-29 | — | — |
MKM Partners | Reiterated | Buy | 2018-12-19 | — | — |
Stifel Nicolaus | Reiterated | Buy | 2018-09-21 | $1500.00 | +52.60% |
Macquarie | Reiterated | Outperform | 2018-09-14 | — | — |
Benchmark | Reiterated | Buy | 2018-06-22 | — | — |
Argus | Reiterated | Buy | 2018-03-26 | — | — |
Standpoint Research | Downgraded | Outperform → Hold | 2017-11-28 | — | — |
Bank of America | Upgraded | Underperform → Buy | 2017-02-09 | — | — |
Summit Redstone Partners | Upgraded | Sell → Buy | 2016-12-22 | — | — |
Brean Capital | Reiterated | Buy | 2016-10-05 | — | — |
Pacific Crest | Reiterated | Overweight | 2016-03-31 | — | — |
Jefferies | Reiterated | Buy | 2015-10-02 | — | — |
Topeka | Reiterated | Buy | 2015-08-17 | — | — |
Topeka Capital | Reiterated | Buy | 2015-08-16 | — | — |
PiperJaffray | Reiterated | Overweight | 2015-08-11 | — | — |
Drexel Hamilton | Downgraded | Buy → Hold | 2015-08-07 | — | — |
JMP Securities | Reiterated | Market Outperform | 2015-05-21 | — | — |
Ladenburg Thalmann | Reiterated | Neutral | 2014-10-08 | — | — |
ISI Group | Downgraded | Strong Buy → Buy | 2014-04-10 | — | — |
Argus Capital | Reiterated | Buy | 2014-01-10 | — | — |
Sterne Agee | Reiterated | Buy | 2013-06-20 | — | — |
Credit Agricole | Downgraded | Outperform → Underperform | 2013-05-02 | — | — |
Lazard | Downgraded | Buy → Neutral | 2013-03-04 | — | — |
Cross Research | Reiterated | Buy | 2012-12-07 | — | — |
ThinkEquity | Reiterated | Buy | 2012-05-18 | — | — |
Oppenheimer | Downgraded | Outperform → Perform | 2012-03-26 | — | — |
Institution
Needham
Reiterated · Buy · 2026-10-22
$1650.00
+67.80%
Rosenblatt
Reiterated · Buy · 2026-10-22
—
—
DA Davidson
Reiterated · Buy · 2026-10-07
$3000.00
+205.10%
Morgan Stanley
Reiterated · Overweight · 2026-10-01
$1200.00
+22.00%
Mizuho
Reiterated · Outperform · 2026-10-01
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2026-10-01
$2000.00
+103.40%
RBC Capital
Reiterated · Outperform · 2026-10-01
$1500.00
+52.60%
TD Cowen
Reiterated · Buy · 2026-10-01
—
—
Baird
Reiterated · Outperform · 2026-09-28
—
—
Wedbush
Reiterated · Outperform · 2026-09-28
$1400.00
+42.40%
Wells Fargo
Reiterated · Overweight · 2026-09-23
$1400.00
+42.40%
Citigroup
Reiterated · Buy · 2026-09-23
—
—
New Street Research
Upgraded · Neutral → Buy · 2026-08-14
—
—
Keybanc
Reiterated · Overweight · 2026-07-14
$1750.00
+78.00%
B of A Securities
Reiterated · Buy · 2026-06-25
—
—
Susquehanna
Reiterated · Positive · 2026-06-25
$2000.00
+103.40%
Deutsche Bank
Reiterated · Buy · 2026-06-25
$1550.00
+57.60%
Raymond James
Reiterated · Outperform · 2026-06-25
$1500.00
+52.60%
Barclays
Reiterated · Overweight · 2026-06-25
$2000.00
+103.40%
Goldman Sachs
Reiterated · Neutral · 2026-06-25
$1250.00
+27.10%
Stifel
Reiterated · Buy · 2026-06-18
—
—
Wolfe Research
Reiterated · Outperform · 2026-06-11
$1300.00
+32.20%
UBS
Reiterated · Buy · 2026-05-26
$1540.00
+56.60%
Melius Research
Reiterated · Buy · 2026-05-19
$2200.00
+123.80%
JP Morgan
Reiterated · Overweight · 2026-03-19
—
—
Bernstein
Reiterated · Outperform · 2026-03-18
$1300.00
+32.20%
Lynx Global
Reiterated · Buy · 2026-01-12
—
—
Piper Sandler
Reiterated · Overweight · 2026-01-07
$400.00
−59.30%
China Renaissance
Downgraded · Buy → Hold · 2025-03-26
—
—
Exane BNP Paribas
Downgraded · Outperform → Underperform · 2024-09-12
—
—
Argus Research
Upgraded · Hold → Buy · 2024-03-21
—
—
Evercore ISI Group
Reiterated · Outperform · 2023-12-21
—
—
BMO Capital
Reiterated · Outperform · 2023-12-18
$1300.00
+32.20%
Credit Suisse
Reiterated · Outperform · 2022-11-16
—
—
Loop Capital
Reiterated · Buy · 2022-10-14
—
—
Summit Insights Group
Upgraded · Hold → Buy · 2022-09-30
—
—
Fox Advisors
Downgraded · Overweight → Equal Weight · 2022-07-05
—
—
Cowen & Co.
Reiterated · Outperform · 2022-07-01
—
—
Cascend
Reiterated · Buy · 2021-03-15
—
—
KeyBanc
Reiterated · Overweight · 2021-03-04
$1750.00
+78.00%
Cleveland Research
Upgraded · Neutral → Buy · 2020-09-23
—
—
Nomura
Reiterated · Neutral · 2020-06-30
—
—
Nomura Instinet
Reiterated · Neutral · 2020-06-30
—
—
Longbow Research
Reiterated · Buy · 2020-01-21
—
—
GF Securities
Reiterated · Accumulate → Buy · 2019-11-29
—
—
MKM Partners
Reiterated · Buy · 2018-12-19
—
—
Stifel Nicolaus
Reiterated · Buy · 2018-09-21
$1500.00
+52.60%
Macquarie
Reiterated · Outperform · 2018-09-14
—
—
Benchmark
Reiterated · Buy · 2018-06-22
—
—
Argus
Reiterated · Buy · 2018-03-26
—
—
Standpoint Research
Downgraded · Outperform → Hold · 2017-11-28
—
—
Bank of America
Upgraded · Underperform → Buy · 2017-02-09
—
—
Summit Redstone Partners
Upgraded · Sell → Buy · 2016-12-22
—
—
Brean Capital
Reiterated · Buy · 2016-10-05
—
—
Pacific Crest
Reiterated · Overweight · 2016-03-31
—
—
Jefferies
Reiterated · Buy · 2015-10-02
—
—
Topeka
Reiterated · Buy · 2015-08-17
—
—
Topeka Capital
Reiterated · Buy · 2015-08-16
—
—
PiperJaffray
Reiterated · Overweight · 2015-08-11
—
—
Drexel Hamilton
Downgraded · Buy → Hold · 2015-08-07
—
—
JMP Securities
Reiterated · Market Outperform · 2015-05-21
—
—
Ladenburg Thalmann
Reiterated · Neutral · 2014-10-08
—
—
ISI Group
Downgraded · Strong Buy → Buy · 2014-04-10
—
—
Argus Capital
Reiterated · Buy · 2014-01-10
—
—
Sterne Agee
Reiterated · Buy · 2013-06-20
—
—
Credit Agricole
Downgraded · Outperform → Underperform · 2013-05-02
—
—
Lazard
Downgraded · Buy → Neutral · 2013-03-04
—
—
Cross Research
Reiterated · Buy · 2012-12-07
—
—
ThinkEquity
Reiterated · Buy · 2012-05-18
—
—
Oppenheimer
Downgraded · Outperform → Perform · 2012-03-26
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space